Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07724899) titled 'Efficacy and Safety of Superior Vena Cava Isolation and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
Primary Sponsor: Qiang Hu
Condition:
Atrial Fibrillation (AF)
Intervention:
Procedure: superior vena cava isolation plus pulmonary Vein isolation
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: July 20, 2026
Target Sample Size: 200
Countries of Recruitment:
Ch...